Bill > HB51

This bill makes two primary changes to New Hampshire's therapeutic cannabis regulations. First, it removes references to "seeds" from the legal definition of cannabis, effectively excluding cannabis seeds from regulatory oversight. Second, the bill allows alternative treatment centers (medical cannabis dispensaries) to purchase and use non-intoxicating hemp-derived cannabinoids, such as CBD, in the manufacture of cannabis concentrates and infused products, with important restrictions. Specifically, these non-intoxicating cannabinoids must be tested for contaminants and cannabinoid profile according to existing department rules, and alternative treatment centers are strictly prohibited from using hemp-derived products containing more than 0.3% THC or any THC isomer variants like delta-8 or delta-9 THC. The bill will take effect 60 days after its passage, providing time for alternative treatment centers and regulators to adjust to the new provisions. The changes aim to provide more flexibility for medical cannabis producers while maintaining strict quality and safety standards.

Health and Social Services, Justice

https://gc.nh.gov/bill_status/legacy/bs2016/bill_docket.aspx?lsr=3&sy=2025&sortoption=&txtsessionyear=2025&txtbillnumber=HB51